Table 2.
Results of the MMPI-2-RF Validity Scales of patients with Noonan syndrome (NS, n = 18) and healthy controls (HC, n = 18)
| MMPI-2-RF Validity Scales | Median raw scores (range) | Mean uniform or linear T-scores (SD) | U | z | p | r | ||
|---|---|---|---|---|---|---|---|---|
| NS | HC | NS | HC | |||||
| VRIN-r | 4 (0–7) | 3.5 (0–6) | 53.94 (11.55) | 50.67 (10.30) | 133.00 | − .93 | .37 | − .16 |
| TRIN-r | 12 (9–12) | 11 (8–13) | 55.39 (8.13) | 51.00 (10.24) | 131.50 | − 1.02 | .34 | − .17 |
| F-r | 4.5 (1–16) | 2.5 (0–10) | 66.56 (18.79) | 55.17 (13.34) | 96.00 | − 2.10 | .04 | − .35 |
| Fp-r | 2 (0–6) | 1 (0–3) | 54.89 (12.48) | 51.11 (8.32) | 137.00 | − .81 | .44 | − .14 |
| Fs-r | 2 (0–9) | 1.5 (0–3) | 61.17 (19.75) | 52.83 (7.78) | 130.50 | − 1.02 | .32 | − .17 |
| FBS-r | 14 (4–22) | 10 (6–17) | 68.67 (15.66) | 57.33 (8.50) | 84.50 | − 2.46 | .01 | − .41 |
| L-r | 4 (1–10) | 4 (1–9) | 47.94 (9.08) | 47.00 (10.31) | 147.00 | − .48 | .65 | − .08 |
| K-r | 6 (1–14) | 7 (1–13) | 43.94 (14.20) | 47.61 (12.53) | 190.5 | .91 | .37 | .15 |
| RBS-r | 10* (4–16) | 7* (3–12) | – | – | 96.00 | − 2.10 | .04 | − .35 |
VRIN-r Variable Response Inconsistency, TRIN-r True Response Inconsistency, F-r Infrequent Responses, Fp-r Infrequent Psychopathology Responses, Fs-r Infrequent Somatic Responses, FBS-r Symptom Validity, L-r Uncommon Virtues, K-r Adjustment Validity, RBS-r Response Bias Scale, U Mann–Whitney’s U statistic, z z-score, r effect size estimate
*No normative data were available for the RBS-r, although both scores were below the cut-off score of 17 indicative for exaggeration of memory complaints (Gervais et al., 2010)